AstraZeneca’s COVID vaccine suffers a setback in nasal spray trial
(Reuters) – Attempts by Oxford University researchers and AstraZeneca Plc to create a nasal-spray version of their jointly developed COVID-19 shot suffered a setback on Tuesday as initial testing on…